Daily Caller patriots exclusive content
Analysis

How America’s Most Elite Consulting Firm Coached Purdue Pharma To Sell More Opioids

NEW YORK, NEW YORK - MARCH 13: Hypodermic needles litter the ground in the South Bronx on March 13, 2019 in New York City. America's drug makers are finding themselves under increased legal scrutiny by states and attorney generals as hundreds of lawsuits tied to the deadly opioid epidemic have been filed against them. (Photo by Spencer Platt/Getty Images)

(Photo by Spencer Platt/Getty Images)

Anders Hagstrom White House Correspondent
Font Size:

McKinsey is nearing a settlement deal with several state attorneys general for its role advising a major pharmaceutical company “turbocharge” its sale of OxyCotin in the middle of the opioid crisis, The Wall Street Journal (WSJ) reported Tuesday.